Where is AddexBio located?

AddexBio is headquartered in San Diego, United States.

How many employees does AddexBio have?

As of Jun 30, 2026, the latest employee count at AddexBio is 2.

Is AddexBio a funded company?

AddexBio is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does AddexBio rank among its competitors?

AddexBio ranks 653rd amongst 863 active competitors, of which 68 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of AddexBio?

AddexBio's top competitors include Abcam, BioLife Solutions and Enzo. Among them, BioLamina secured the most recent funding round in April, 2026.

AddexBio - 2026 Company Profile, Team & Competitors

AddexBio is an unfunded company based in San Diego (United States), founded in 2010 by Patrick Yu. It operates as a Provider of comprehensive preclinical services, cell lines, and research reagents. AddexBio has not raised any funding yet. The company has 863 active competitors, including 68 funded and 115 that have exited. Its top competitors include companies like Abcam, BioLife Solutions and Enzo.

Company Details

Provider of comprehensive preclinical services, cell lines, and research reagents. The company offers medicinal chemistry, bioanalytical screening, and study services, including signaling pathway mapping and various in vitro and in vivo assays. Expertise extends to drug metabolism, pharmacokinetics, preclinical cardiac safety assessment, and cancer cell line screening. A wide array of cell lines, including cancer, immortalized, normal, and primary cells, are available. The company also provides biotinylated reagents, fluorescently labeled peptides, and cell culture reagents. Services include cell authentication and mycoplasma testing. The company supports research with technical assistance, order support, and resources for FDA compliance, ensuring quality and reliability in preclinical research.

Website: addexbio.com
Social
Email ID: *****@addexbio.com
Phone Number: +1 **********

Key Metrics

Founded Year

2010

Location

San Diego, United States

Stage

Unfunded

Ranked

653^rd among 863 active competitors

Employee Count

2 as on Jun 30, 2026

Similar Companies

Abcam & 1028 more

View AddexBio's full profile

AddexBio has not raised any funding rounds yet.

The founders of AddexBio is Patrick Yu.

Here are the details of AddexBio's key team members:

Patrick Yu: Founder of AddexBio.

View details of AddexBio's Founder profiles and Board Members

AddexBio's employee count trend

AddexBio has 2 employees as of Jun 26. Here is AddexBio's employee count trend over the years:

Uncover AddexBio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of AddexBio include Abcam, BioLife Solutions and Enzo. Here is the list of Top 10 competitors of AddexBio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	76/100
2nd	BioLife Solutions 1987, Bothell (United States), Public	Developer of cell and gene therapies with the integrity of a single cell	-	-	67/100
3rd	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	65/100
4th	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
5th	Integrated DNA Technologies 1987, Coralville (United States), Acquired	Provider of oligonucleotide-based reagents and kits	-	Summit Partners, Golub Capital & 1 others	63/100
6th	RoosterBio 2012, Frederick (United States), Series B	Developer of human mesenchymal stem cells and extracellular vesicles	$38.4M	Planetary Technologies, Dynamk Capital & 4 others	61/100
7th	Firefly BioWorks 2009, Cambridge (United States), Acquired	Develops platform to allow multiplexed assays on standard laboratory instrumentation	$3.77M	Breton Capital Ventures, PBM Capital & 3 others	59/100
8th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
9th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	BDC, National Research Council Canada & 1 others	58/100
10th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100
653rd	AddexBio 2010, San Diego (United States), Unfunded	Provider of comprehensive preclinical services, cell lines, and research reagents	-	-	23/100